Page 49 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) over placebo. RBX2660 is an investigational, potential first-in-class microbiota-based live biotherapeutic

Eating too often through the day, even if we’re choosing healthy foods, may undermine our resistance to chronic diseases that can kick in as we age, say experts.

May 19, 2021 Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona Print this news Download... | May 19, 2021

Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona News provided by Share this article - AMBAR ® Center combines Grifols' more than 15 years of knowledge researching this devastating disease with the experience of the non-profit medical foundation Ace Alzheimer Center Barcelona in diagnosing and treating Alzheimer's patients, including application of AMBAR ® (Alzheimer Management by Albumin Replacement) - The AMBAR ® clinical program, based on periodic plasma exchange with albumin, has shown a delay in the cognitive ...

Advances in the Care of Patients with Heart Failure: Reducing Hospital Readmission Rates This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation. 0.75 CME Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again l...